NCT04349202View on ClinicalTrials.gov

Beaumont Health Large-scale Automated Serologic Testing for COVID-19

CompletedOBSERVATIONAL
Enrollment

20,614

Participants

Timeline

Start Date

April 10, 2020

Primary Completion Date

January 19, 2021

Study Completion Date

January 19, 2021

Conditions
COVID-19Coronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2
Interventions
DIAGNOSTIC_TEST

EUROIMMUN assay

Serology testing to detect SARS-CoV-2 antibodies

Trial Locations (2)

48073

Beaumont Health System, Royal Oak

Beaumont Health, Royal Oak

All Listed Sponsors
lead

William Beaumont Hospitals

OTHER

NCT04349202 - Beaumont Health Large-scale Automated Serologic Testing for COVID-19 | Biotech Hunter | Biotech Hunter